Emily K. Bergsland, MD

President Emeritus

Nominating Committee Chair

Awards Committee Chair

Medical Oncology, University of California, San Francisco School of Medicine

Dr. Emily Bergsland is Professor of Clinical Medicine, UCSF; Associate Director for Education, Helen Diller Family Comprehensive Cancer Center and holds the Ernest Rosenbaum, MD, Endowed Chair in Medical Oncology, UCSF.

Dr. Bergsland is a specialist in gastrointestinal oncology. Her expertise extends to the treatment of gastrointestinal cancers, with an emphasis on colorectal and neuroendocrine malignancies. In her research, she focuses on developing and testing novel cancer therapies. She has also written extensively on the evolution of neuroendocrine tumor treatment. Dr. Bergsland has led numerous clinical studies in patients with gastrointestinal malignancies. Her current efforts are focused on clinical and translational research related to neuroendocrine tumors. At a national level, Dr. Bergsland is a member of the NCCN (National Comprehensive Cancer Network) NET guidelines panel and past Chair of the Neuroendocrine Tumor (NET) Task Force for the National Cancer Institute. She is also the study chair for a national study of a novel treatment for patients with carcinoid tumors performed by the ALLIANCE for Clinical Trials and funded by the National Cancer Institute.

Dr. Bergsland earned her medical degree from the University of Minnesota and completed an internship, residency, and chief residency in internal medicine at UCSF. She subsequently completed a fellowship in Medical Oncology and was a Molecular Medicine fellow before joining the UCSF faculty in 1998. 

Dr. Bergsland is President of the North American Neuroendocrine Tumor Society (NANETS).

More about Dr. Bergsland